Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Reflecting on 9/11: Cramer's 'Mad Money' Recap
By Scott Rutt
Oct 24, 2018 11:04 PM EDT
PRESS RELEASES
Biologics License Application For Narsoplimab In HSCT-TMA Accepted For Priority Review By U.S. FDA
By Business Wire
Jan 19, 2021 8:30 AM EST
PRESS RELEASES
Omeros To Present At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 11, 2021 4:30 PM EST
PRESS RELEASES
CMS Confirms Continued Separate Payment For Omeros' FDA-Approved OMIDRIA® In Ambulatory Surgery Centers
By Business Wire
Dec 3, 2020 7:30 AM EST
PRESS RELEASES
Omeros Submits Its Biologics License Application To U.S. FDA For Narsoplimab In HSCT-TMA
By Business Wire
Nov 18, 2020 9:00 AM EST
PRESS RELEASES
Omeros Corporation To Announce Third Quarter Financial Results On November 9, 2020
By Business Wire
Nov 5, 2020 7:00 AM EST
PRESS RELEASES
Omeros Participates In Investor Conference Focused On COVID-19 Therapeutics In Development
By Business Wire
Oct 28, 2020 9:00 AM EDT
PRESS RELEASES
Omeros Reports Final Efficacy And Safety Data From The Narsoplimab Pivotal Trial In HSCT-TMA
By Business Wire
Oct 22, 2020 8:00 AM EDT
PRESS RELEASES
Omeros' OMS906 Data Presented At Complement-based Drug Development Summit
By Business Wire
Oct 16, 2020 8:30 AM EDT
PRESS RELEASES
Omeros Schedules Webcast To Present Final Efficacy Results From Narsoplimab BLA For The Treatment Of HSCT-TMA
By Business Wire
Oct 15, 2020 8:00 AM EDT
PRESS RELEASES
Omeros Provides Update On Separate Payment For OMIDRIA® In The ASCs
By Business Wire
Oct 1, 2020 9:00 AM EDT
PRESS RELEASES
Omeros To Present At The Cantor Virtual Global Healthcare Conference
By Business Wire
Sep 11, 2020 7:00 AM EDT
PRESS RELEASES
Expert Panel Points To Central Role Of Endothelial Injury And Lectin Pathway Activation In Critically Ill COVID-19 Patients
By Business Wire
Sep 3, 2020 9:38 AM EDT
PRESS RELEASES
Omeros' Investigational New Drug Application For OMS906 Cleared By FDA
By Business Wire
Aug 31, 2020 8:00 AM EDT
PRESS RELEASES
Omeros Announces Pricing Of Public Offerings
By Business Wire
Aug 12, 2020 6:30 AM EDT
PRESS RELEASES
Omeros Announces Proposed Public Offerings Of Common Stock And Convertible Senior Notes
By Business Wire
Aug 10, 2020 4:12 PM EDT
PRESS RELEASES
Omeros Corporation Reports Recovery And Survival Of All Patients In Study Evaluating Narsoplimab For Treatment Of COVID-19-Associated Acute Respiratory Distress Syndrome
By Business Wire
Aug 10, 2020 7:30 AM EDT
PRESS RELEASES
Omeros' Narsoplimab Pivotal Trial Data Shared In Oral Presentation At Annual European Hematology Association Congress
By Business Wire
Jun 12, 2020 8:30 AM EDT
PRESS RELEASES
Omeros' Narsoplimab Pivotal Trial Data To Be Shared As An Oral Presentation At Annual European Hematology Association Congress
By Business Wire
Jun 11, 2020 8:45 AM EDT
PRESS RELEASES
Omeros Corporation Announces Presentation Of Narsoplimab Pivotal Trial Data At Upcoming European Hematology Association Annual Congress
By Business Wire
May 14, 2020 9:00 AM EDT
PRESS RELEASES
Omeros Corporation To Announce First Quarter Financial Results On May 11, 2020
By Business Wire
May 5, 2020 7:00 AM EDT
PRESS RELEASES
Ranpak Appoints Former Amazon Global Treasurer To Its Board Of Directors
By Business Wire
Mar 4, 2020 6:45 AM EST
PRESS RELEASES
Omeros Corporation Reports Updated Results From Narsoplimab HSCT-TMA Clinical Trial And Highlights From Recent Clinical And CMC Meetings With FDA
By Business Wire
Mar 2, 2020 4:01 PM EST
PRESS RELEASES
Omeros Corporation To Announce Fourth Quarter And Year-End 2019 Financial Results On March 2, 2020
By Business Wire
Feb 24, 2020 7:00 AM EST
PRESS RELEASES
Omeros Corporation Appoints Former Amazon Treasurer Kurt Zumwalt To Board Of Directors
By Business Wire
Feb 11, 2020 8:30 AM EST
